Riluzole protects against cardiac ischaemia and reperfusion damage via block of the persistent sodium current
Open Access
- 25 March 2010
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 160 (5), 1072-1082
- https://doi.org/10.1111/j.1476-5381.2010.00766.x
Abstract
Background and purpose: Current strategies to ameliorate cardiac ischaemic and reperfusion damage, including block of the sodium‐hydrogen exchanger, are therapeutically ineffective. Here we propose a different approach, block of the persistent sodium current (INaP). Experimental approach: Left ventricular pressure was measured as an index of functional deficit in isolated, Langendorff perfused, hearts from adult rats, subjected to 30 min global ischaemia and reperfusion with vehicle only (control) or riluzole (1–10 µM) in the perfusate. Cell shortening and intracellular Ca2+ concentrations [Ca2+]i were measured in adult rat isolated myocytes subjected to hypoxia and re‐oxygenation. The block of transient and persistent sodium currents by concentrations of riluzole between 0.01 and 100 µM were assessed in rat isolated myocytes using patch clamp techniques. Key results: In perfused hearts, riluzole produced a concentration‐dependent cardioprotective action, with minor protection from 1 µM and produced rapid and almost complete recovery upon reperfusion from 3 and 10 µM. In isolated myocytes, riluzole at 3 and 10 µM greatly attenuated or prevented the hypoxia‐ and reperfusion‐induced rise in [Ca2+]i and the contractile deficit. In patch clamp experiments, riluzole blocked the persistent sodium current with an IC50 of 2.7 µM, whereas the block of the transient sodium current was only apparent at concentrations above 30 µM. Conclusions and implications: Riluzole preferentially blocked INaP and was protective in cardiac ischaemia and reperfusion. Thus block of the persistent sodium current would be a viable method of ameliorating cardiac ischaemic and reperfusion damage.Keywords
This publication has 42 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 4th editionBritish Journal of Pharmacology, 2009
- Why did the NHE inhibitor clinical trials fail?Journal of Molecular and Cellular Cardiology, 2009
- F 15845 inhibits persistent sodium current in the heart and prevents angina in animal modelsBritish Journal of Pharmacology, 2009
- Inhibition of late sodium current to reduce electrical and mechanical dysfunction of ischaemic myocardiumBritish Journal of Pharmacology, 2008
- The cardiac persistent sodium current: an appealing therapeutic target?British Journal of Pharmacology, 2008
- Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazineHeart, 2006
- Pharmacological Approaches To Repair the Injured Spinal CordJournal of Neurotrauma, 2006
- Defective calcium handling in cardiomyocytes isolated from hearts subjected to ischemia-reperfusionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- RiluzoleDrugs, 1996
- Inactivation-resistant channels underlying the persistent sodium current in rat ventricular myocytesProceedings Of The Royal Society B-Biological Sciences, 1994